Skip to Content

Join the 'Serophene' group to help and get support from people like you.

Serophene News

Fewer Birth Defects for Older Moms Who Have Fertility Treatments

Posted 17 Oct 2016 by

MONDAY, Oct. 17, 2016 – Older women who get pregnant through assisted reproduction may be less likely to have babies with birth defects than those who conceive naturally, a new Australian study suggests. The findings challenge the widely held belief that assisted reproduction increases the risk of birth defects in all women, according to the researchers at the University of Adelaide. "There's something quite remarkable occurring with women over the age of 40 who use assisted reproduction," study lead author Michael Davies said in a university news release. He is a professor and epidemiologist at the university's Robinson Research Institute. The researchers looked at information from births in South Australia between 1986 and 2002. The study included more than 301,000 naturally conceived births, 2,200 in vitro fertilization (IVF) births and nearly 1,400 births from intracytoplasmic ... Read more

Related support groups: Clomid, Female Infertility, Ovulation Induction, HCG, Clomiphene, Pregnyl, Hydrocephalus, Oligospermia, Gonal-f, Novarel, Primary Ovarian Failure, Menopur, Brain Anomalies incl Congenital, Serophene, Ovidrel, Follicle Stimulation, Follistim, Menotropins, Chorionic Gonadotropin (Hcg, Gonal-f RFF

Fertility Treatments Not Linked to Twins' Birth Defects

Posted 21 Jun 2016 by

TUESDAY, June 21, 2016 – Twins born after fertility treatments may be susceptible to different – and fewer – birth defects than other twins, new research suggests. The study confirms that twins have a higher risk of birth defects than singletons, but it questions the notion that fertility treatments contribute to those abnormalities. "Our results suggest that the risks of specific types of birth defects in twins may be different depending on whether fertility treatments were used," said study lead author April Dawson, a health scientist with the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention. Jeffrey Roth, a research professor of pediatrics with the University of Florida, said the findings "may begin to lower the anxiety of women who receive fertility treatment that their offspring face an elevated risk of birth ... Read more

Related support groups: Clomid, Female Infertility, Ovulation Induction, Clomiphene, Primary Ovarian Failure, Follicle Stimulation, Serophene, Milophene

Kids Born Through IVF Show No Higher Risk for Developmental Delays: Study

Posted 4 Jan 2016 by

MONDAY, Jan. 4, 2016 – Preschoolers who were conceived through fertility treatments don't seem to have any special risk of developmental delays, a new study suggests. The researchers said the findings, published online Jan. 4 in the journal JAMA Pediatrics, should be reassuring to the growing number of U.S. couples seeking help with infertility. There have long been lingering concerns about the development of children conceived through infertility treatment, explained study author Edwina Yeung, a researcher at the U.S. National Institute of Child Health and Human Development. That's partly based on animal research, Yeung said, and partly because of conflicting findings from studies of children. A few studies of children have suggested there might be developmental effects, at least with certain types of fertility treatment. But many others have found no such link, the researchers noted. ... Read more

Related support groups: Clomid, Female Infertility, Delivery, Ovulation Induction, Clomiphene, Primary Ovarian Failure, Serophene, Follicle Stimulation, Cetrotide, Labor and Delivery including Augmentation, Fertinex, Milophene, Bravelle

For Unexplained Infertility, Breast Cancer Drug No Better Than Standard Treatment

Posted 23 Sep 2015 by

WEDNESDAY, Sept. 23, 2015 – A breast cancer drug that is sometimes used to treat infertility may reduce a couple's risk of having a pregnancy with multiple babies – but it might also slightly lower their chances of having a baby at all, a new clinical trial suggests. The study did not find the cancer drug letrozole (Femara) more effective than standard fertility drugs for women with unexplained infertility. In research reported last year, letrozole actually improved birth rates among women who were infertile due to polycystic ovarian syndrome compared to a widely used fertility drug called clomiphene (Clomid). In contrast, the new study focused on women age 40 and younger whose infertility had no clear cause. "For them, we can't say that letrozole is as good as standard drugs when it comes to your chances of going home with a baby," said lead researcher Dr. Michael Diamond, professor ... Read more

Related support groups: Polycystic Ovary Syndrome, Clomid, Female Infertility, Femara, Letrozole, Ovulation Induction, Clomiphene, Primary Ovarian Failure, Serophene, Follicle Stimulation, Milophene

Breast Cancer Drug May Help Women Fight a Leading Cause of Infertility: Study

Posted 10 Jul 2014 by

WEDNESDAY, July 9, 2014 – Women with polycystic ovary syndrome have a better chance of getting pregnant if they take a breast cancer drug instead of the currently preferred medication, a new study suggests. Polycystic ovary syndrome – the most common cause of female infertility in the United States – causes higher than normal levels of the male hormone androgen, infrequent periods and small cysts on the ovaries. It affects 5 to 10 percent of reproductive-age women, according to background information in the study. Currently, doctors typically prescribe clomiphine (Clomid) to boost fertility for women with polycystic ovary syndrome. However, this new study suggests the drug letrozole (Femara) results in better ovulation, conception and birth rates. "We found a simple and comparatively safe and vastly more effective treatment for [polycystic ovary syndrome]," said lead researcher Dr. ... Read more

Related support groups: Polycystic Ovary Syndrome, Clomid, Female Infertility, Femara, Letrozole, Clomiphene, Serophene, Milophene

'Generally Reassuring' Findings on Fertility Drugs, Women's Cancers

Posted 3 Jul 2014 by

WEDNESDAY, July 2, 2014 – Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian and uterine cancers, new research indicates. The findings are "generally reassuring," said study co-author Dr. Humberto Scoccia, of the University of Illinois at Chicago. Still, he urged that women who use fertility drugs be closely monitored as they age. Nearly 10,000 women who underwent infertility treatment in the United States between 1965 and 1988 were followed for 30 years for the study. During the follow-up, 749 cases of breast cancer, 119 cases of uterine cancer and 85 cases of ovarian cancer were diagnosed among the women. Fertility drugs increase levels of the hormones estradiol and progesterone, which have been associated with these women's cancers. Clomiphene citrate was the most commonly used fertility drug until the 1980s, the study authors noted. The ... Read more

Related support groups: Clomid, Female Infertility, Clomiphene, Serophene, Milophene

Fertility Drugs May Not Raise Breast Cancer Risk: Study

Posted 3 Apr 2014 by

THURSDAY, April 3, 2014 – Widely used fertility drugs don't seem to increase a woman's risk of breast cancer, according to a new study. Researchers analyzed data from more than 9,800 American women who were evaluated for infertility between 1965 and 1988 and followed until 2010. During the follow-up period, 749 of the women developed breast cancer. Overall, women who took Clomid (clomiphene citrate) or gonadotropins as part of fertility treatments were not more likely to develop breast cancer than those who didn't take the drugs, according to the study in the current issue of the journal Cancer Epidemiology, Biomarkers and Prevention. "We wanted to evaluate the long-term relationship of fertility medications and breast cancer risk after controlling for other factors that have been shown to be correlated with both breast cancer risk and use of those drugs," Louise Brinton, chief of the ... Read more

Related support groups: Clomid, Female Infertility, HCG, Pregnyl, Clomiphene, Chorionic Gonadotropin, Novarel, Serophene, Ovidrel, Chorionic Gonadotropin (Hcg, Profasi, Milophene, Chorigon, APL, Profasi HP, Choron-10, Gonic, Chorex

Can Fertility Treatments Influence Later Breast Cancer Risk?

Posted 6 Jul 2012 by

FRIDAY, July 6 – Whether or not a woman becomes pregnant while on fertility drugs may affect her odds for breast cancer later on, a new study suggests. However, experts who reviewed the study said it has flaws and is far from conclusive. In the study, published July 6 in the Journal of the National Cancer Institute, women using ovulation-stimulating fertility drugs who were unable to get pregnant for at least 10 weeks had a lower risk of the disease than women who have not taken the drugs, the U.S. study found. On the other hand, the odds of breast cancer rose for women who became pregnant for at least 10 weeks after taking the fertility drugs, when compared to women who were unsuccessfully treated with these drugs. However, the risk for women who became pregnant while on fertility drugs rose only high enough to put it on par with women who had never taken fertility drugs, the ... Read more

Related support groups: Breast Cancer, Clomid, Female Infertility, Clomiphene, Gonal-f, Serophene, Follistim AQ, Follistim, Follicle Stimulating Hormone, Gonal-f RFF, Puregon, Follistim/Antagon, Gonal-F Pen, Follicle Stimulating Hormone/Ganirelix, Gonal-f RFF Pen, Follistim AQ Cartridge, Milophene

IVF, Fertility Drugs Might Boost Autism Risk

Posted 19 May 2010 by

WEDNESDAY, May 19 – Children whose mothers took fertility drugs were almost twice as likely to have autism as other children, new research finds. Being conceived by in vitro fertilization (IVF) or born prematurely also seemed to up the risk of autism, according to another study. In the first study, researchers asked 111 women taking part in the Nurses' Health Study II who had a child with an autism spectrum disorder about their history of fertility problems and use of ovulation-inducing drugs, such as Clomid or gonadotropins. About 34 percent of moms with an autistic child had used fertility drugs compared to about 24 percent of some 3,900 mothers without an autistic child, the researchers found. Clomid and gonadotropins are often used as a first-line treatment for infertility, defined as trying for a year or longer to get pregnant without success, said lead study author Kristen Lyall, ... Read more

Related support groups: Clomid, Female Infertility, Pregnyl, Clomiphene, Chorionic Gonadotropin, Gonal-f, Novarel, Menopur, Serophene, Ovidrel, Follistim AQ, Chorionic Gonadotropin (Hcg, Follistim, Follicle Stimulating Hormone, Ganirelix, Menotropins, Gonal-f RFF, Profasi, Chorex, Luveris

Ask a Question

Further Information

Related Condition Support Groups

Female Infertility, Oligospermia, Ovulation Induction, Lactation Suppression

Serophene Patient Information at